CNSide Diagnostics, LLC is a company dedicated to developing and commercializing proprietary clinical diagnostic laboratory assays. The first-in-class CNSide™ assay is performed in a CLIA-registered facility in Houston, Texas at the request of top cancer physicians in the U.S.
CNSide™ is a highly sensitive, cerebrospinal fluid-based, laboratory developed test (LDT) for patients with Leptomeningeal Metastases (LM) from carcinomas and melanomas. By enabling quantitative analysis and molecular characterization of tumor cells, we provide powerful insights to healthcare providers that guide patient care and treatment decisions.
Company Details
- Employees
- 4
- Address
- 2710 Reed Rd,
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- https://cnside-dx.com/
- HQ
- Houston, Texas
Cnside Diagnostics Questions
Cnside Diagnostics's website is https://cnside-dx.com/
Cnside Diagnostics's LinkedIn profile is https://www.linkedin.com/company/cnsidediagnostics
Cnside Diagnostics has
4 employees.
View email and phone details for 4
employees at Cnside Diagnostics.
Cnside Diagnostics's industry is
Medical and Diagnostic Laboratories
Cnside Diagnostics's top competitors are
Paragon Facilities Management Llc,
Biomédicas Youth School,
Hospice,
Kreienbaum Neoscience Gmbh,
Md Anderson Cancer Center,
Plus Therapeutics, Inc.,
Destina Genomica Sl,
Accessdx Laboratory,
Medcure, Inc.,
Hooke Bio Ltd..
Cnside Diagnostics's categories are Medical and Diagnostic Laboratories
